Technological advancements in insulin pens, pumps, and continuous glucose monitoring systems have greatly improved the convenience and effectiveness of rapid acting insulin. Current delivery devices ...

Inhaled Technosphere insulin (TI) failed to meet noninferiority for HbA1c vs subcutaneous rapid-acting analog (RAA) insulin in youth.

A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...

Regular (R) insulin is a short-acting, injectable insulin used for the management of diabetes. It is typically taken before meals to prevent glucose from rising after a person eats. Regular insulin is ...

(MENAFN- GlobeNewsWire - Nasdaq) Growth is driven by increasing demand for personalized treatment, improved delivery technologies, and biosimilars, despite challenges like high costs and regulatory ...